Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.62 |
| ▸ | PAM | P19021 | 2/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | PPARD | Q03181 | 7/20 | 0.55 |
| ▸ | PPARA | Q07869 | 7/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.55 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanoic Acid SCHEMBL31096997 | 1.00 | DGKA (0.62) | DGKAPAMGPR84PPARGPPARD | |
| Stearic Acid SCHEMBL27719642 | 0.94 | MAPT (0.56) | DGKAPAMGPR84PPARGPPARD | |
| SCHEMBL27842955 | 0.93 | DGKA (0.50) | DGKAPAMGPR84PPARGPPARD | |
| SCHEMBL2032699 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 | |
| SCHEMBL19409845 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 | |
| SCHEMBL23141646 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 | |
| SCHEMBL120186 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 | |
| SCHEMBL2397395 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 | |
| SCHEMBL856632 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 | |
| SCHEMBL37144 | 0.93 | DGKA (0.71) | DGKAPAMTSHRALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680186-A1 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | claimed |
| EP-4680185-A1 | SKIN CARE COMPOSITION | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | claimed |
| WO-2024189014-A1 | SKIN CARE COMPOSITION | DSM IP ASSETS B.V. (NL) | 2024-09-19 | — | — | WO | claimed |
| WO-2024189016-A1 | SUNSCREEN COMPOSITION | DSM IP ASSETS B.V. (NL) | 2024-09-19 | — | — | WO | claimed |
| EP-2208768-B1 | A bituminous cold glue | IMPERBEL N V SA (BE) | 2013-03-27 | — | — | EP | claimed |
| US-8257483-B2 | Bituminous cold glue | S.A. IMPERBEL N.V. (BE) | 2012-09-04 | — | — | US | claimed |
| US-20100212546-A1 | Bituminous cold glue | S.A. IMPERBEL N.V. (BE) | 2010-08-26 | — | — | US | claimed |
| EP-2208768-A1 | A bituminous cold glue | S.A. Imperbel N.V. (BE) | 2010-07-21 | — | — | EP | claimed |
| US-20260083652-A1 | RENEWABLE ESTER EMOLLIENT FOR ENHANCED CUTANEOUS PERMEATION | OXITENO S.A. INDÚSTRIA E COMÉRCIO (BR) | 2026-03-26 | — | — | US | disclosed |
| EP-4680186-A1 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680185-A1 | SKIN CARE COMPOSITION | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680185-A1 | SKIN CARE COMPOSITION | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680186-A1 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| WO-2026002977-A1 | SUNSCREEN COMPOSITION | DSM IP ASSETS B.V. (NL) | 2026-01-02 | — | — | WO | disclosed |
| WO-2024189014-A1 | SKIN CARE COMPOSITION | DSM IP ASSETS B.V. (NL) | 2024-09-19 | — | — | WO | disclosed |
| WO-2024189014-A1 | SKIN CARE COMPOSITION | DSM IP ASSETS B.V. (NL) | 2024-09-19 | — | — | WO | disclosed |
| EP-2208768-B1 | A bituminous cold glue | IMPERBEL N V SA (BE) | 2013-03-27 | — | — | EP | disclosed |
| US-8257483-B2 | Bituminous cold glue | S.A. IMPERBEL N.V. (BE) | 2012-09-04 | — | — | US | disclosed |
| US-20100212546-A1 | Bituminous cold glue | S.A. IMPERBEL N.V. (BE) | 2010-08-26 | — | — | US | disclosed |
| EP-2208768-A1 | A bituminous cold glue | S.A. Imperbel N.V. (BE) | 2010-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083652-A1 | RENEWABLE ESTER EMOLLIENT FOR ENHANCED CUTANEOUS PERMEATION | ELOVL3, CRAT, ELOVL5 | DGKA 2073/4885PAM 4565/4885GPR84 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.